Pfizer Strikes $190M Deal To Settle Neurontin Antitrust MDL
Pfizer Inc. on Monday agreed to pay $190 million to settle a class action coursing through New Jersey federal court alleging that the drug giant conspired to bar competition for its...To view the full article, register now.
Already a subscriber? Click here to view full article